Bio Port Korea Inc. (KOSDAQ:188040)
South Korea
· Delayed Price · Currency is KRW
13,890
-10 (-0.07%)
At close: Aug 14, 2025, 3:30 PM KST
Bio Port Korea Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
FY 2024 | FY 2023 |
Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Revenue | 73,346 | 68,699 |
Revenue Growth (YoY) | 6.77% | - |
Cost of Revenue | 52,411 | 49,616 |
Gross Profit | 20,936 | 19,083 |
Selling, General & Admin | 14,507 | 13,179 |
Research & Development | 504.95 | 457.61 |
Other Operating Expenses | 163.69 | 133.25 |
Operating Expenses | 15,696 | 14,164 |
Operating Income | 5,240 | 4,919 |
Interest Expense | -1,512 | -2,108 |
Interest & Investment Income | 517.44 | 408.99 |
Currency Exchange Gain (Loss) | 544.78 | 206.96 |
Other Non Operating Income (Expenses) | 1,467 | 182.24 |
EBT Excluding Unusual Items | 6,258 | 3,609 |
Gain (Loss) on Sale of Investments | 18.23 | -13.91 |
Gain (Loss) on Sale of Assets | -924.59 | - |
Pretax Income | 5,352 | 3,595 |
Income Tax Expense | 1,240 | 225.62 |
Net Income | 4,112 | 3,369 |
Net Income to Common | 4,112 | 3,369 |
Net Income Growth | 22.04% | - |
Shares Outstanding (Basic) | 3 | 3 |
Shares Outstanding (Diluted) | 4 | 4 |
Shares Change (YoY) | 1.04% | - |
EPS (Basic) | 1465.53 | 1347.75 |
EPS (Diluted) | 1438.99 | 1302.58 |
EPS Growth | 10.47% | - |
Free Cash Flow | 8,491 | -1,253 |
Free Cash Flow Per Share | 2372.83 | -353.75 |
Gross Margin | 28.54% | 27.78% |
Operating Margin | 7.14% | 7.16% |
Profit Margin | 5.61% | 4.91% |
Free Cash Flow Margin | 11.58% | -1.82% |
EBITDA | 7,102 | 6,328 |
EBITDA Margin | 9.68% | 9.21% |
D&A For EBITDA | 1,862 | 1,409 |
EBIT | 5,240 | 4,919 |
EBIT Margin | 7.14% | 7.16% |
Effective Tax Rate | 23.16% | 6.28% |
Advertising Expenses | 966.01 | 768.83 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.